Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barna Szima
Observed names:
B Szima,
B. Szima
Institution:
Markusovszky Egyetemi Oktatókórház
Observed institutions:
Genentech,
Institut Gustave Roussy,
Centre Hospitalier Universitaire de Montpellier,
Markusovszky Egyetemi Oktatókórház,
Országos Korányi Tbc és Pulmonológiai Intézet
OpenAlex ID:
A5087260997
Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer
2011
·
Jean-Charles Soria
, Zsuzsanna Márk
, et al.
·
Journal of Clinical Oncology
·
273
PDF
A Correlative Biomarker Analysis of the Combination of Bevacizumab and Carboplatin-Based Chemotherapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: Results of the Phase II Randomized ABIGAIL Study (BO21015)
2014
·
Tony Mok
, Vera Gorbunova
, et al.
·
Journal of Thoracic Oncology
·
58
Clinical genotyping and efficacy outcomes: Exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer
2014
·
Celine Pallaud
, Martin Reck
, et al.
·
Lung Cancer
·
24
A randomized phase II study of paclitaxel (P) and carboplatin (C) ± bevacizumab (B) ± dulanermin (D) in non-small cell lung cancer (NSCLC).
2010
·
F. H. Blackhall
, Z. Márk
, et al.
·
Journal of Clinical Oncology
·
10
9003 ORAL Biomarker Analysis in BO21015, a Phase II Randomised Study of First-line Bevacizumab (BEV) Combined With Carboplatin-gemcitabine (CG) or Carboplatin-paclitaxel (CP) in Patients (pts) With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer (NSCLC)
2011
·
T. Mok
, V. Gorbunova
, et al.
·
European Journal of Cancer
·
8
6610 POSTER Safety of bevacizumab treatment in non-small cell lung cancer (NSCLC) subjects receiving full-dose anti-coagulation (FDAC) treated on protocol BO17704
2007
·
N. Leighl
, J. Bennouna
, et al.
·
European Journal of Cancer Supplements
·
7
Tracheobronchial Silicone Stent Implantation with the Flexible Bronchoscope
1994
·
János Strausz
, Sándor Kis
, et al.
·
Journal of Bronchology
·
7
103P First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)
2021
·
Z.G. Andric
, G. Gálffy
, et al.
·
Journal of Thoracic Oncology
·
5
PDF
Safety of Bevacizumab Treatment in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Full-Dose Anticoagulation (FDAC) Treated on Protocol BO17704
2007
·
J. Skillings
, F. LaFleur
, et al.
·
Clinical Lung Cancer
·
4
Tumour Biomarker and Plasma Time Course Data from Abigail, A Phase II Study of 1st-Line Bevacizumab + Chemotherapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC)
2012
·
M. Reck
, V.A. Gorbunova
, et al.
·
Annals of Oncology
·
3
PDF
6526 POSTER Review of pulmonary haemorrhage (PH) in non-small cell lung cancer (NSCLC) subjects receiving bevacizumab and cisplatin plus gemcitabine on protocol BO17704
2007
·
V. Hirsh
, J. Bennouna
, et al.
·
European Journal of Cancer Supplements
·
3
Clinical Genotyping and Efficacy Outcomes: Exploratory Biomarker Data from the Phase II Abigail Study of 1st-Line Bevacizumab + Chemotherapy in Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC)
2012
·
C. Pallaud
, M. Reck
, et al.
·
Annals of Oncology
·
2
PDF
Manifestations of systemic mycoses and related infections in the central nervous system
2009
·
Balázs Tahin
, Justin Cooke
, et al.
·
Orvosi Hetilap
·
2
PDF
Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC
2023
·
Zoran Andric
, Gabriella Gálffy
, et al.
·
JTO Clinical and Research Reports
·
1
[Fiberoptic bronchoscopy in intensive care units].
1996
·
K Kiss
, Z Pápai
, et al.
·
PubMed
·
1
[The role of Nd-YAG in the management of tracheobronchial stenosis].
1994
·
J Strausz
, S Kis
, et al.
·
PubMed
·
1
Decreased serum cholesterol level in pulmonary tuberculosis
1994
·
J. Moldvay
, Csóka M. Németh
, et al.
·
Tubercle and Lung Disease
·
1
Review of Pulmonary Hemorrhage (PH) in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Bevacizumab and Cisplatin plus Gemcitabine on Protocol BO17704
2007
·
F. LaFleur
, J. Skillings
, et al.
·
Clinical Lung Cancer
The oesophageal metallic stenting – A new palliative treatment of malignant oesophageal stenoses and broncho-oesophageal fistulas
2004
·
L Lakner
, A Kovács
, et al.
·
Zeitschrift für Gastroenterologie
[Experience with transbronchial lung biopsy].
1994
·
B Szima
, Z Pápai
, et al.
·
PubMed
Flexible fiberoptic bronchoscopy (FFB) in intensive care units (ICU)
1994
·
K. Kiss
, Zs. Pápai
, et al.
·
Tubercle and Lung Disease
Flexible fiberoptic bronchoscopy in intensive care units
1994
·
Katalin Kiss
, Zs. Pápai
, et al.
[Combination of high dose after-loading radiation therapy and percutaneous irradiation in the management of tumors of the major airways].
1994
·
S Kis
, A Naszály
, et al.
·
PubMed
Show more works
View as search
Works count:
23
Citation count:
410
H-index:
7
I10-index:
4
Year
Topic
Type